PMV Pharmaceuticals, Inc.
PMVP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,059 | -$21,210 | -$17,436 | -$23,000 |
| Dep. & Amort. | $32 | $32 | $37 | $39 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,668 | $1,508 | $1,271 |
| Change in WC | $522 | $1,914 | -$1,535 | $1,445 |
| Other Non-Cash | $685 | -$706 | -$840 | $3,584 |
| Operating Cash Flow | -$19,820 | -$18,302 | -$18,266 | -$16,661 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $1 | -$11 | -$4 | -$56 |
| Net Acquisitions | $1 | $30 | $0 | $0 |
| Inv. Purchases | -$20,473 | -$30,962 | -$15,727 | -$37,513 |
| Inv. Sales/Matur. | $32,499 | $41,929 | $44,445 | $45,091 |
| Other Inv. Act. | $0 | $0 | $0 | $222 |
| Investing Cash Flow | $12,028 | $10,986 | $28,714 | $7,744 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $103 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $10 | $172 |
| Financing Cash Flow | $0 | $103 | $10 | $172 |
| Forex Effect | $2 | -$1 | $7 | -$11 |
| Net Chg. in Cash | -$7,790 | -$7,214 | $10,465 | -$8,756 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44,127 | $51,341 | $40,876 | $49,632 |
| End Cash | $36,337 | $44,127 | $51,341 | $40,876 |
| Free Cash Flow | -$19,819 | -$18,313 | -$18,270 | -$16,717 |